Last 12 months
Inside the activity.
0 purchase rows · 417 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 29 |
| Dec 2025 | 0 | 48 |
| Jan 2026 | 0 | 27 |
| Feb 2026 | 0 | 26 |
| Mar 2026 | 0 | 18 |
| Apr 2026 | 0 | 54 |
| May 2026 | 0 | 46 |
| Jun 2026 | 0 | 19 |
| Jul 2026 | 0 | 50 |
| Aug 2026 | 0 | 53 |
| Sep 2026 | 0 | 26 |
| Oct 2026 | 0 | 21 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 14, 2021 Filed Dec 17, 2021 01:51 UTC |
Chadwick JonathanDirector
|
GrantClass B Common Stock · Derivative | 488,246 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-048674 · doc4.xml · derivative · entry 1 Chadwick Jonathan · CIK 0001375800 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 488,246 Underlying: Class B Common Stock · 488,246 shares Expires not disclosed F1 · security: The reported shares are represented by restricted stock units, or RSUs, of which 152,576 vested upon the effectiveness of the Issuer's registration statement in connection with its initial public offering of Class A Common Stock and the remaining shares vest in quarterly installments beginning on March 15, 2022 through September 15, 2024. F2 · derivative.exercise_date: The Class B Common Stock is convertible at any time, at the holder's election, into Class A Common Stock on a 1:1 basis. F2 · derivative.expiration_date: The Class B Common Stock is convertible at any time, at the holder's election, into Class A Common Stock on a 1:1 basis. Read SEC document |
| December 14, 2021 Filed Dec 17, 2021 01:53 UTC |
LIVERMORE ANN MDirector
|
GrantClass B Common Stock · Derivative | 200,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-048677 · doc4.xml · derivative · entry 1 LIVERMORE ANN M · CIK 0001207622 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,000 Underlying: Class B Common Stock · 200,000 shares Expires not disclosed F1 · security: The reported shares are represented by restricted stock units, or RSUs, that vest as to 1/4 of the total shares subject to the RSU on June 15, 2022 and thereafter in quarterly installments beginning on September 15, 2022 through June 15, 2025. F2 · derivative.exercise_date: The Class B Common Stock is convertible at any time, at the holder's election, into Class A Common Stock on a 1:1 basis. F2 · derivative.expiration_date: The Class B Common Stock is convertible at any time, at the holder's election, into Class A Common Stock on a 1:1 basis. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.